CPRT Forensic analysis

Trading Setup & Entry Strategy

Copart (CPRT) is currently in a BEARISH_DOWNTREND and is testing critical support levels. Given the negative price action and analyst skepticism, this is NOT a V-shaped recovery play.

• >Entry Zone: WAIT for a retest of $32.50. If the $32.50 support (Bollinger Band floor) holds, enter a small 25% position as a mean-reversion scalp.
• >Stop Loss: HARD stop at $31.90. A daily close below this level signals a breakdown to $30.00.
• >Scaling: If the stock bounces, add 25% on a confirmed break of the 10-day SMA ($33.24).
• >Take Profit: Target $34.00 (Upper Bollinger Band) and $35.00.
• >Risk/Reward: Targeting 1:2.5.
• >Max Hold Time: 5 Days (Swing Trade).

Executive Summary

CPRT is struggling with margin compression and a negative narrative shift as noted in recent research (Simply Wall St.). Despite a strong cash position ($5.10B) and aggressive share buybacks, the stock is trapped under its 50-day and 200-day SMAs. Rating: HOLD/WAIT.

Financial Health & Forensics

• >Revenue Quality: Service revenues decreased 4% in the latest quarter due to the lapping of one-time hurricane-related tailwinds from FY2025.
• >Cash Flow: Strong operating cash flow ($662M), but significant capital allocated to repurchases at $39.82/share implies management believes shares are undervalued, yet the market disagrees, pushing price to $33.12.
• [WARN]Warning Flags: Regulatory risk regarding the ongoing DOJ money laundering investigation remains a material uncertainty.

Technical Reconciliation

The stock is in a confirmed BEARISH_DOWNTREND (Price < SMA50 < SMA200). While the MACD is showing a marginal bullish signal, it is not supported by volume or trend. The RSI at 47.34 is range-bound, suggesting a lack of conviction from buyers.

Short-Term Trading Strategy (2-5 Days)

• >Timeframe: Swing Trade (2–5 Days).
• >Position Size: 2% of portfolio.
• >Catalyst Timing: Q3 FY2026 earnings are upcoming. DO NOT hold through the earnings print due to high volatility and guidance uncertainty.
• >Risk/Reward: Entry $32.80, Stop $31.90, Target $34.50 (Approx. 1:2.0 R/R).

Investment Recommendation

HOLD. The fundamental value is obfuscated by the current regulatory investigation (DOJ) and the negative sentiment surrounding revenue execution. The stock is a 'Value Trap' until it can reclaim the 200-day SMA at $40.06.

One-Liner Thesis: Copart is a cash-rich compounder currently suffering from a 'hangover' post-hurricane revenue spikes and regulatory scrutiny, requiring a technical breakout above the 50-day SMA before initiating a long-term position.